We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

BEBPA Europe Bioassays Conference

Learn about tools for Structural and Functional Characterization of Proteins and Therapeutic Antibodies from Promega.

  • The Aquincum Hotel, Budapest, Hungary.
  •  Wednesday, September 26, 2018 – Friday, September 28, 2018

Bioassays to Power Your Immunotherapy Program

Attend our podium presentation and visit the can’t-miss poster presentations on quantitative MOA-based bioassays for functional characterization, potency and stability testing of antibodies. Learn more about our Fc Effector, Immune Checkpoint and T Cell Activation Bioassays.

BEBPA EUROPE

PODIUM PRESENTATION

Application of MOA-Based Reporter Bioassays for Immunotherapy Drug Development
Presented by:
Jey Cheng, Sr Research Scientist
Friday, September 28, 4:30pm

SCIENTIFIC POSTER PRESENTATIONS

Hitting the Gas: Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Co-Stimulatory Immune Checkpoint Receptors
Presented by:
Gopal Krishnan, Global Product Manager
Releasing the Brakes: Quantitative Cell-Based Bioassays to Advance Individual or Combination Immune Checkpoint Immunotherapy
Presented by:
Jey Cheng, Sr Research Scientist
Measurement of Fc-Mediated ADCC and CDC Activity of anti-TNFα and anti-VEGF Therapeutic Antibodies using Reporter-Based Bioassays and Engineered TNFα+ and VEGF+ Target Cells
Presented by:
Axel Johann, Key Account Manager
Improved T Cell Activation Bioassays to Advance the Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
Presented by:
Richard Somberg, Director, Pharma/Biotech Market Segment
Reproducible MOA-Reflecting Reporter-Based Bioassays to Enable Drug Development of Biosimilars and Biobetters
Presented by:
Reka Nagy, Strategic Collaborations Manager

Share With a Friend

We will NOT sell your personal information, such as your name or email address, to third parties or use your email address to send you marketing materials. The email and names entered will only be used to identify the sender and recipient of the email.

Send Cancel